모노아실글리세롤 리파제 억제제의 결정질 형태

MAGL 억제제인 1-(1-(2-(피롤리딘-1-일)-4-(트리플루오로메틸)벤질)-1,8-디아자스피로[4.5]데칸-8-카르보닐)-1H-피라졸-3-카르복실산의 새로운 결정질 형태, 또는 이의 약제학적으로 허용 가능한 염이 본 명세서에 기재되어 있다. Described herein are new crystalline forms of the MAGL inhibitor 1-(1-(2-(pyrrolidin-1-yl)-4-(trifluoromethyl)benzyl)-1,8-diazaspiro[4.5]decane-8-carbonyl)-1H-pyr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	WIENER JOHN J.M, JUHL MARTIN, GANCEDO SUSANA DEL RIO, CINCOTTI ANTONIO, ALLAN AMY, PATTERSON ADAM ROSS, BUZARD DANIEL J, LOPEZ DE DIEGO HEIDI, ANDREW SAMUEL GEORGE, VETTER THOMAS, GRICE CHERYL A, EDWARDS RICHARD JAMES
Format:	Patent
Sprache:	kor
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	MAGL 억제제인 1-(1-(2-(피롤리딘-1-일)-4-(트리플루오로메틸)벤질)-1,8-디아자스피로[4.5]데칸-8-카르보닐)-1H-피라졸-3-카르복실산의 새로운 결정질 형태, 또는 이의 약제학적으로 허용 가능한 염이 본 명세서에 기재되어 있다. Described herein are new crystalline forms of the MAGL inhibitor 1-(1-(2-(pyrrolidin-1-yl)-4-(trifluoromethyl)benzyl)-1,8-diazaspiro[4.5]decane-8-carbonyl)-1H-pyrazole-3-carboxylic acid, or a pharmaceutically acceptable salt thereof.